דילוג לתוכן הראשי
xMedica

NCT07321899ClinicalTrials.gov

Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation

Transcatheter Tricuspid Valve Replacement Using the Medtronic Intrepid™ TTVR System in Patients With Severe Symptomatic Tricuspid Regurgitation - PATHFINDER

מגייסמקבל משתתפים כעת, לפי רשומת המרשם.
יצירת קשר עם המחקר

בקצרה

This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.

התערבותידרושים 1,186 משתתפים20 אתריםמדינה אחת

קטגוריות

רשום במרשם אחד

מחקר יחיד יכול להיות רשום בכמה מרשמים. אנו מציגים אותו פעם אחת ומקשרים לכל רשומה שברשותנו.

מידע הניסוי מוצג כפי שפורסם על ידי המרשם, בשפת המקור שלו.

מתעניינים במחקר הזה?

התחברות או צרו חשבון כדי לרשום את התעניינותכם ולעקוב אחר המחקר הזה.

How this study is set up

The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.

  • Present: Registered before enrolment beganFirst posted 2026-01-07; recorded start 2026-09-11
  • Present: Has a defined primary outcomeA primary outcome measure is listed in the record
  • Present: The primary outcome states a time frameThe primary outcome measure records a time frame
  • Present: Participants are randomly assignedAllocation is recorded as randomised
  • Present: Has a comparison groupThe record lists a placebo or comparator arm, or more than one study arm
  • Present: Uses blinding (masking)A masking level is recorded in the record
  • Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
  • Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
  • Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
  • Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
  • Present: Sponsor has 19 other studies in this databaseCounted from the lead sponsor named in the record (Medtronic Cardiovascular)
  • Present: Sponsor has posted results for at least one studyBased on the sponsor’s studies in this database
  • The record lists 1 condition.
  • Lead sponsor type recorded as: industry.

Trial stature

Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.

Methodological rigourSTRONG

A strong methodological design for a study of this type, judged from its ClinicalTrials.gov record.

How this score is built
  • Randomised allocation20/20

    Participants are randomly allocated between arms

  • Blinding7/20

    Single-blind

  • Control arm15/15

    Active-comparator control arm

  • Primary-outcome specificity10/10

    Named primary outcome with a defined time frame

  • Endpoint type3/10

    Surrogate or intermediate endpoint (conservative default)

  • Multi-centre5/8

    Multi-centre: 4 sites

  • Data monitoring committee7/7

    A data monitoring committee is in place

  • Prospective registration5/5

    Registered before the study start date

  • Protocol / SAP posted0/5

    No protocol or SAP posted to the registry

ScaleLARGE

A large study: 1,186 participants (target), run at 20 sites.

How this score is built
  • Enrolment31/40

    1,186 participants (target)

  • Site count7/25

    4 sites

  • Country count0/15

    Single country

  • Planned duration10/10

    Planned over about 179 months

  • Sponsor scale4/10

    Medtronic Cardiovascular has led 19 trials in our corpus

Investigator standingUNKNOWN

We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.

How this score is built
  • Investigator standing0/100

    No investigator recorded in the registry for this trial

These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.

תקציר

This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.

Prospective, global, pre-market, interventional, multi-center, randomized controlled pivotal trial to evaluate the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System compared to Edwards EVOQUE TTVR System in symptomatic patients with severe or greater tricuspid regurgitation.

מצבים רפואיים

  • Severe Tricuspid Regurgitation

זכאות

זכאות
מיןהכול
גילאים18 Years – ללא מקסימום
מתנדבים בריאיםלא

זכאות כפי שנכתבה במרשם

Inclusion Criteria: * Age ≥18 years at the time of consent. * Severe symptomatic tricuspid regurgitation (TR) despite optimal medical therapy (OMT). * Local site multidisciplinary heart team experienced in tricuspid valve therapies agrees that the subject is appropriate for TTVR. Exclusion Criteria: * Any tricuspid device currently in place. * Anatomic contraindications. * Need for emergent or urgent surgery. * Left ventricular ejection fraction \<25%.

זכאות במשפטים פשוטים

הקריטריונים של רשומה זו טרם פורקו למשפטים נפרדים. טקסט המרשם שלמעלה שלם והוא הגרסה המחייבת.

תכנון המחקר

תכנון המחקר
סוג המחקרהתערבותי
שלבלא רלוונטי
הקצאהאקראי
מודל ההתערבותPARALLEL
מטרה ראשיתTREATMENT
הסתרהSINGLE (1)
גיוסדרושים 1,186 משתתפים

נותן חסות ושותפים

  • Medtronic Cardiovascular נותן חסות

זרועות והתערבויות

  • Medtronic Intrepid™ TTVREXPERIMENTAL

    Transcatheter tricuspid valve replacement with Medtronic Intrepid™ TTVR System in patients with severe or greater tricuspid regurgitation.

  • Edwards EVOQUE TTVRACTIVE_COMPARATOR

    Transcatheter tricuspid valve replacement with Edwards EVOQUE TTVR in patients with severe or greater tricuspid regurgitation.

  • Single Arm RegistryEXPERIMENTAL

    Transcatheter tricuspid valve replacement with Medtronic Intrepid™ TTVR System in patients with severe or greater tricuspid regurgitation who are not eligible for randomization.

התערבויות

  • התקן Edwards EVOQUE Tricuspid Valve Replacement (TTVR) System

    Transcatheter Tricuspid Valve Replacement

  • התקן Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System

    Transcatheter Tricuspid Valve Replacement

מדדי תוצאה

  1. מדד תוצאה ראשוני

    Rate of Major Adverse Events (MAE)

    מסגרת זמן 30-days post-procedure

  2. מדד תוצאה ראשוני

    Composite Endpoint: All-cause mortality, Heart failure hospitalization, and tricuspid valve reintervention

    מסגרת זמן 1-year post-procedure

  3. מדד תוצאה משני

    Tricuspid regurgitation (TR) grade reduction

    Total number of patients with at least one grade TR reduction

    מסגרת זמן 6 months post-procedure

  4. מדד תוצאה משני

    Change in quality of life (QoL) as measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ) from baseline

    KCCQ overall summary score is a patient-reported measure of health status. Scores range from 0 to 100 where higher scores reflect better quality of life

    מסגרת זמן 6 months post-procedure

  5. מדד תוצאה משני

    All-cause mortality

    מסגרת זמן 12 months post-procedure

  6. מדד תוצאה משני

    Heart failure hospitalization

    מסגרת זמן 12 months post-procedure

  7. מדד תוצאה משני

    New onset conduction disturbance (NOCD)

    מסגרת זמן 30 days post-procedure

  8. מדד תוצאה משני

    Total procedure time

    מסגרת זמן Procedure

  9. מדד תוצאה משני

    Right ventricle (RV) dysfunction

    מסגרת זמן 12 months post-procedure

תאריכים

תאריכים
תאריך התחלה11 בספטמבר 2026 (בפועל)
סיום ראשוני1 בספטמבר 2031 (משוער)
סיום1 באפריל 2041 (משוער)
פורסם לראשונה7 בינואר 2026 (בפועל)
עודכן לאחרונה12 בנובמבר 2026
התוצאות פורסמולא צוין ברשומת המרשם
המצב אומת לאחרונהנובמבר 2026

בפועל פירושו שהאירוע התרחש. משוער פירושו שנותן החסות צופה אותו. שתי המשמעויות שונות זו מזו.

מיקומים

20 אתרים מגייסים

United States

United States
מתקןעירמדינה או אזורמצב
Emory University Hospital MidtownAtlantaGeorgiaמגייס
University of Alabama at Birmingham (UAB) HospitalBirminghamAlabamaמגייס
Buffalo General Medical CenterBuffaloNew Yorkמגייס
Northwestern Memorial HospitalChicagoIllinoisמגייס
The Christ HospitalCincinnatiOhioמגייס
Cleveland Clinic FoundationClevelandOhioמגייס
Hartford HospitalHartfordConnecticutמגייס
Cedars Sinai Medical CenterLos AngelesCaliforniaמגייס
Northwell Health North Shore University HospitalManhassetNew Yorkמגייס
Abbott Northwestern HospitalMinneapolisMinnesotaמגייס
Morristown Medical CenterMorristownNew Jerseyמגייס
Yale New Haven HospitalNew HavenConnecticutמגייס
Montefiore Medical CenterNew YorkNew Yorkמגייס
NYU Langone Medical CenterNew YorkNew Yorkמגייס
The Valley HospitalParamusNew Jerseyמגייס
Abrazo Arizona Heart HospitalPhoenixArizonaמגייס
Kaiser Permanente San Francisco Medical CenterSan FranciscoCaliforniaמגייס
Los Robles Hospital & Medical CenterThousand OaksCaliforniaמגייס
Ascension Via Christi Saint FrancisWichitaKansasמגייס
Lankenau Institute for Medical ResearchWynnewoodPennsylvaniaמגייס

מסמכי המחקר

לא צורפו מסמכים ברשומת מרשם זו.

שינויים לאורך זמן

  1. 12 בנובמבר 2026

    אתר נוסף

    7 sites added (20 total)

    1320

  2. 25 בספטמבר 2026

    אתר נוסף

    9 sites added (13 total)

    413

  3. 28 ביולי 2026

    המצב השתנה

    Status changed from Not yet recruiting to Recruiting

    NOT_YET_RECRUITINGRECRUITING

  4. 28 ביולי 2026

    הגיוס נפתח

    Recruitment opened

    NOT_YET_RECRUITINGRECRUITING

  5. 28 ביולי 2026

    אתר נוסף

    4 sites added (4 total)

    04